{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:10:30Z","timestamp":1790169030446,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["2 - 172722"],"award-info":[{"award-number":["2 - 172722"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ebiom.2021.103700","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:35:34Z","timestamp":1638275734000},"page":"103700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2"],"prefix":"10.1016","volume":"74","author":[{"given":"Yannick","family":"Galipeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayakumar","family":"Siragam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaeline","family":"McGuinty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Durocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Cuperlovic-Culf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffany A.L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Gigu\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-3029","authenticated-orcid":false,"given":"Marc-Andr\u00e9","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ebiom.2021.103700_bib0001","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.cell.2021.02.010","article-title":"Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection","volume":"184","author":"Anderson","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103700_bib0002","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/JCM.00636-10","article-title":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method","volume":"48","author":"Gaunt","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103700_bib0003","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","author":"Edridge","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103700_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/v12060630","article-title":"Epidemiology and Clinical Symptoms Related to Seasonal Coronavirus Identified in Patients with Acute Respiratory Infections Consulting in Primary Care over Six Influenza Seasons (2014-2020) in France","volume":"12","author":"Masse","year":"2020","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103700_bib0005","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1128\/CVI.00278-10","article-title":"Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum","volume":"17","author":"Gorse","year":"2010","journal-title":"Clinical and Vaccine Immunology"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0006","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1038\/s41467-021-23074-3","article-title":"Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection","volume":"12","author":"Song","year":"2021","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ebiom.2021.103700_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146316","article-title":"A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2","volume":"6","author":"Majdoubi","year":"2021","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103700_bib0008","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'kovski","year":"2021","journal-title":"Nature Reviews Microbiology"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103700_bib0009","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s10875-021-00997-6","article-title":"Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses","volume":"41","author":"Hicks","year":"2021","journal-title":"J Clin Immunol"},{"issue":"559","key":"10.1016\/j.ebiom.2021.103700_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc3103","article-title":"A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations","volume":"12","author":"Grzelak","year":"2020","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103700_bib0011","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3201\/eid2607.200841","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103700_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107725","article-title":"Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections","volume":"31","author":"Lv","year":"2020","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0013","article-title":"Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses","volume":"2","author":"Ladner","year":"2021","journal-title":"Cell Rep Med"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103700_bib0014","article-title":"Distinct antibody repertoires against endemic human coronaviruses in children and adults","volume":"6","author":"Khan","year":"2021","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0015","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41598-018-37747-5","article-title":"Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses","volume":"9","author":"Trivedi","year":"2019","journal-title":"Scientific Reports"},{"issue":"3382","key":"10.1016\/j.ebiom.2021.103700_bib0016","article-title":"Humoral Responses and Serological Assays in SARS-CoV-2 Infections","volume":"11","author":"Galipeau","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103700_bib0017","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103700_bib0018","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103700_bib0019","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.cell.2021.02.035","article-title":"Extremely potent human monoclonal antibodies from COVID-19 convalescent patients","volume":"184","author":"Andreano","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103700_bib0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.immuni.2021.03.023","article-title":"Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant","volume":"54","author":"Graham","year":"2021","journal-title":"Immunity"},{"issue":"7847","key":"10.1016\/j.ebiom.2021.103700_bib0021","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103700_bib0022","article-title":"Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset","volume":"2","author":"Anand","year":"2021","journal-title":"Cell Rep Med"},{"issue":"18","key":"10.1016\/j.ebiom.2021.103700_bib0023","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142386","article-title":"Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity","volume":"5","author":"McAndrews","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103700_bib0024","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell."},{"issue":"7833","key":"10.1016\/j.ebiom.2021.103700_bib0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"issue":"7821","key":"10.1016\/j.ebiom.2021.103700_bib0026","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0027","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/22221751.2020.1761267","article-title":"Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2","volume":"9","author":"Anderson","year":"2020","journal-title":"Emerging Microbes & Infections"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103700_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100126","article-title":"Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike","volume":"1","author":"Pr\u00e9vost","year":"2020","journal-title":"Cell Reports Medicine"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0029","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143380","article-title":"Recent endemic coronavirus infection is associated with less-severe COVID-19","volume":"131","author":"Sagar","year":"2021","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0030","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1038\/s41467-020-18450-4","article-title":"A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity","volume":"11","author":"Huang","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.ebiom.2021.103700_bib0031","article-title":"Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection","author":"Poston","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103700_bib0032","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146927","article-title":"Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality","volume":"131","author":"Morgenlander","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0033","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41591-020-01143-2","article-title":"Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells","volume":"27","author":"Schulien","year":"2021","journal-title":"Nat Med"},{"issue":"6512","key":"10.1016\/j.ebiom.2021.103700_bib0034","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.abd3871","article-title":"Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans","volume":"370","author":"Mateus","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jiaa680","article-title":"Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"223","author":"Henss","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2021.103700_bib0036","doi-asserted-by":"crossref","unstructured":"Colwill K, Galipeau Y, Stuible M, Gervais C, Arnold C, Rathod B, et\u00a0al. A \u201cMade-in-Canada\u201d serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination. medRxiv 2021.10.25.21265476. doi: 10.1101\/2021.10.25.21265476.","DOI":"10.1002\/cti2.1380"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103700_bib0037","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1214\/009053607000000505","article-title":"Measuring and testing dependence by correlation of distances","volume":"35","author":"Sz\u00e9kely","year":"2007","journal-title":"The Annals of Statistics"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0038","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1025667309714","article-title":"Theoretical and Empirical Analysis of ReliefF and RReliefF","volume":"53","author":"Robnik-\u0160ikonja","year":"2003","journal-title":"Machine Learning"},{"key":"10.1016\/j.ebiom.2021.103700_bib0039","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jbiotec.2017.06.009","article-title":"Rapid protein production from stable CHO cell pools using plasmid vector and the cumate gene-switch","volume":"255","author":"Poulain","year":"2017","journal-title":"J Biotechnol"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103700_bib0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cll.2009.07.007","article-title":"Recently discovered human coronaviruses","volume":"29","author":"Wevers","year":"2009","journal-title":"Clin Lab Med"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0041","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Current Protocols in Microbiology"},{"issue":"52","key":"10.1016\/j.ebiom.2021.103700_bib0042","doi-asserted-by":"crossref","first-page":"eabe5511","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Science Immunology"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103700_bib0043","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2010.06.004","article-title":"Kinetics of maternal antibodies against rubella and varicella in infants","volume":"29","author":"Leuridan","year":"2011","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.ebiom.2021.103700_bib0044","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1016\/j.vaccine.2007.06.020","article-title":"Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns","volume":"25","author":"Leuridan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2021.103700_bib0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2014","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103700_bib0046","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jcv.2011.11.011","article-title":"The dominance of human coronavirus OC43 and NL63 infections in infants","volume":"53","author":"Dijkman","year":"2012","journal-title":"J Clin Virol"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103700_bib0047","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/CVI.00124-08","article-title":"Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population","volume":"15","author":"Severance","year":"2008","journal-title":"Clinical and Vaccine Immunology"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103700_bib0048","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/JCM.00533-08","article-title":"Human Coronavirus NL63 and 229E Seroconversion in Children","volume":"46","author":"Dijkman","year":"2008","journal-title":"Journal of Clinical Microbiology"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0049","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/22221751.2020.1813636","article-title":"Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach","volume":"9","author":"van Tol","year":"2020","journal-title":"Emerging Microbes & Infections"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103700_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/v12030254","article-title":"Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0051","doi-asserted-by":"crossref","first-page":"16561","DOI":"10.1038\/s41598-020-73491-5","article-title":"SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients","volume":"10","author":"Algaissi","year":"2020","journal-title":"Scientific Reports"},{"issue":"559","key":"10.1016\/j.ebiom.2021.103700_bib0052","doi-asserted-by":"crossref","first-page":"eabc3103","DOI":"10.1126\/scitranslmed.abc3103","article-title":"A comparison of four serological assays for detecting anti\u2013SARS-CoV-2 antibodies in human serum samples from different populations","volume":"12","author":"Grzelak","year":"2020","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0053","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5415\/apallergy.2011.1.1.12","article-title":"Immunoglobulin E in health and disease","volume":"1","author":"Amarasekera","year":"2011","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.ebiom.2021.103700_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100193","article-title":"Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19","author":"Goh","year":"2021","journal-title":"Cell Reports Medicine"},{"issue":"19","key":"10.1016\/j.ebiom.2021.103700_bib0055","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142362","article-title":"A simple protein-based surrogate neutralization assay for SARS-CoV-2","volume":"5","author":"Abe","year":"2020","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.ebiom.2021.103700_bib0056","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138759","article-title":"Kinetics of viral load and antibody response in relation to COVID-19 severity","volume":"130","author":"Wang","year":"2020","journal-title":"The Journal of Clinical Investigation"},{"issue":"7821","key":"10.1016\/j.ebiom.2021.103700_bib0057","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"issue":"6504","key":"10.1016\/j.ebiom.2021.103700_bib0058","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103700_bib0059","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein","volume":"26","author":"Zost","year":"2020","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103700_bib0060","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41467-021-22236-7","article-title":"Systems serology detects functionally distinct coronavirus antibody features in children and elderly","volume":"12","author":"Selva","year":"2021","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103700_bib0061","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.cell.2020.10.039","article-title":"beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway","volume":"183","author":"Ghosh","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103700_bib0062","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'Kovski","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2021.103700_bib0063","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijid.2021.02.085","article-title":"Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)","volume":"105","author":"Dugas","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"6520","key":"10.1016\/j.ebiom.2021.103700_bib0064","doi-asserted-by":"crossref","first-page":"eabd4250","DOI":"10.1126\/science.abd4250","article-title":"Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity","volume":"370","author":"Shrock","year":"2020","journal-title":"Science"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:34:06Z","timestamp":1778873646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421004941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":64,"alternative-id":["S2352396421004941"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103700","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.16.21260079","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103700"}}